000303171 000__ 01716cam\a2200385\a\4500
000303171 001__ 303171
000303171 005__ 20210513112201.0
000303171 008__ 050422s2005\\\\dcua\\\\\b\\\\000\0\eng\\
000303171 010__ $$a  2005011718
000303171 0167_ $$a101246622$$2DNLM
000303171 020__ $$a1933286024 (pbk.)
000303171 0291_ $$aNLM$$b101246622
000303171 035__ $$a(OCoLC)ocm59817895
000303171 035__ $$a303171
000303171 040__ $$aDNLM/DLC$$cDLC$$dIG#$$dNLM$$dUWC$$dOCLCQ$$dBAKER$$dOCLCQ$$dISE
000303171 043__ $$ad------
000303171 049__ $$aISEA
000303171 05000 $$aHD9675.V333$$bD443 2005
000303171 08200 $$a338.4/7615372$$222
000303171 1001_ $$aBarder, Owen.
000303171 24510 $$aMaking markets for vaccines :$$bideas to action : report of the Center for Global Development working group /$$cAlice Albright, Michael Kremer, Ruth Levine, co-chairs ; [lead report authors, Owen Barder, Michael Kremer, Ruth Levine.].
000303171 260__ $$a[Washington, D.C.] :$$bCenter for Global Development,$$cc2005.
000303171 300__ $$axi, 113 p. :$$bcol. ill. ;$$c28 cm.
000303171 504__ $$aIncludes bibliographical references (p. 70-79).
000303171 5050_ $$aWe need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- $3 billion per disease -- Meeting industry requirements -- How sponsors can do it.
000303171 650_0 $$aVaccines industry$$zDeveloping countries.
000303171 650_0 $$aVaccines$$xResearch$$xEconomic aspects$$zDeveloping countries.
000303171 650_0 $$aPharmaceutical industry$$zDeveloping countries.
000303171 650_0 $$aDrugs$$zDeveloping countries.
000303171 7001_ $$aAlbright, Alice.
000303171 7001_ $$aKremer, Michael,$$d1964-
000303171 7001_ $$aLevine, Ruth,$$d1959-
000303171 7102_ $$aCenter for Global Development.
000303171 85200 $$bgen$$hHD9675.V333$$iD443$$i2005
000303171 85641 $$3Table of contents$$uhttp://www.loc.gov/catdir/toc/ecip0511/2005011718.html
000303171 909CO $$ooai:library.usi.edu:303171$$pGLOBAL_SET
000303171 980__ $$aBIB
000303171 980__ $$aBOOK
000303171 994__ $$aC0$$bISE